"The Nifty has been forming higher tops and higher bottoms; it has also closed above the previous swing’s high which is a positive sign," S...

The company's US subsidiary, Lupin Pharmaceuticals Inc has launched the generic Niaspan tablets in multiple strengths of 500mg, 750 mg & 10...

'We do expect nicotinic acid and Aspen to be launched by the end of this quarter,' says Ramesh Swaminathan.

Given the overall technical picture, there is a strong possibility of a price breakout occurring at the end of February 2014.

As many as seven brokerage firms have a target price of over Rs 1,000, which translates into gains of over 10 per cent in the next one year.

The stock has extended overnight gains after the company reported a Q4 net profit of Rs 408 crore, up 161 pc YoY.

Pfizer’s shares will likely plunge after the world’s biggest drugmaker unexpectedly ended development of its most important new drug, a cho...